Status:

COMPLETED

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

Lead Sponsor:

Washington University School of Medicine

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

Brief Summary

This study is evaluating the feasibility of using helical tomotherapy to deliver IMRT in post-hysterectomy endometrial cancer patients receiving adjuvant radiotherapy.

Eligibility Criteria

Inclusion

  • Age greater than or equal to 18 years of age
  • Karnofsky Performance Status of greater than or equal to 60
  • FIGO Surgical Stage I, II, and III
  • Pathologic confirmation of endometrial cancer
  • Patient status post hysterectomy
  • Patients with local or regional metastases are eligible for this protocol, but not those with distant metastases
  • Patients must have adequate:
  • Bone Marrow Function:
  • ANC ≥ 1,500/mcl (\< CTCAE v 3.0 Grade 1).
  • Platelets ≥ 100,000/mcl (\< CTCAE v3.0 Grade 1).
  • Renal Function:
  • Serum creatinine ≤ institutional upper limit normal (ULN) (CTCAE v 3.0 Grade 0). Note: if serum creatinine \> ULN, a 24-hour creatinine clearance must be collected and must be \> 50 mL/min.
  • Hepatic Function:
  • Bilirubin ≤ 1.5 x ULN (\< CTCAE v 3.0 Grade 1).
  • SGOT≤ 2.5 x ULN (\< CTCAE v 3.0 Grade 1).
  • Alkaline phosphatase ≤ 2.5 x ULN (\< CTCAE v 3.0 Grade 1).
  • Neurologic Function:
  • Neuropathy (sensory and motor) \< CTCAE v 3.0 Grade 1.

Exclusion

  • Age less than 18 years of age
  • Karnofsky Performance Status less than 60
  • Radiographic or pathologic evidence of metastatic disease (other than pelvic or para-aortic lymph nodes)
  • Prior pelvic radiation therapy

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT00334321

Start Date

April 1 2006

End Date

September 1 2015

Last Update

October 5 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110